The Series B round led by Spark Capital values 5-year old Abridge, which is used by 5,000 doctors, at $200 million. But it’s up against Nuance, which Microsoft bought for $18.8 billion and is used by half a million doctors.
The American Heart Association has identified a new medical condition that links heart disease to several other health conditions, including kidney disease, diabetes and obesity—offering new guidance in testing those as young as 30 for the chronic ailments.
Almost all of the brains examined by researchers at Boston University’s CTE Center showed the earliest stages of CTE, a study out Monday found.
Reed Jobs will head the firm that stems from Emerson Collective, which his mother Laurene Powell Jobs created and largely funded with the Apple founder’s fortune.
With millions of patients under its belt, digital health startup K Health is looking to scale its artificial intelligence technology in hospitals, starting with new strategic investor Cedars-Sinai.
The test, capable of detecting Parkinson’s before the onset of symptoms, “launches a new, biological era in Parkinson’s research” and could pave the way for a cure, said researcher Kenneth Marek.
Candida auris, a type of yeast, can trigger lethal, highly invasive infections and is increasingly resistant to what few antifungal drugs we have to treat it.
Tuberculosis is one of humanity’s biggest killers and the only licensed TB vaccine, BCG, was developed more than 100 years ago.
Super fit and super rich property developer Tim Gurner shares his 14 favourite biohacks for longevity, performance, brainpower and stress management.
Forbes Australia Editor-in-Chief Sarah O’Carroll gives a sneak peak on what to expect from Forbes Australia issue #2. On sale now.